Latest
Psychedelics on The Frontlines
</pre> Hardships of a Critical Workforce Canadian non-profit Therapsil is advocating for doctors and therapists to legally trip on mushrooms. They’re joined by initiatives from Novamind and Cybin to highlight healthcare workers. Focus will remain …
Exploring the Third Wave
We’re off this week so instead of our regular Briefing, were bringing you an interview from RoP contributor David Adhira with Paul Austin, CEO and Founder of Third Wave. Who is Paul Austin? I had …
Predicting who will quit drugs based on their trip report
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Psychedelic advancements for women, strokes, anxiety, and Californians.
</pre> Psychedelics decriminalization bill passes in California Senate Senate Bill 519, which would allow the possession and sharing of psilocybin, MDMA, LSD, ketamine and ibogaine for people aged 21+, passed in the California Senate in …
Breaking free from a negativity bias with psychedelics
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Texas, California Push Psychedelics Forward
</pre> Groundbreaking Psychedelics Bill Approved by Texas Senate Following the efforts put forth by the likes of former governor Rick Perry, lawmakers in Texas have approved groundbreaking new psychedelics legislation. House-passed bill will require the …
Your genes and psychedelics
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Therapists Get Approval For Liftoff
</pre> FDA okays MDMA for therapists in Phase 1 PTSD trial The Food and Drug Administration has authorized therapists who are being trained to deliver psychedelic treatments to participate in a Phase 1 trial studying …
The most complete picture of our brain on psychedelics
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Toad Time
</pre> A $125 million bet on toad venom GH Research, a Dublin-based biotech company just closed on a Series B funding round worth a cool $125 million. They’re betting on 5-MeO-DMT, aka toad venom, to …